The ‘Hemoglobinopathies Market’ research report provides a succinct analysis on the recent market trends. In addition, the report offers a thorough abstract on the statistics, market estimates and revenue forecasts, which further highlights its position in the industry, in tandem with the growth strategies adopted by leading industry players.
Global Hemoglobinopathies Market is valued at USD 5.74 Billion in 2018 and expected to reach USD 11.08 Billion by 2025 with the CAGR of 9.85% over the forecast period.
Increasing need of screening for sickle cell disease specifically in newborns is anticipated to drive the growth of Global Hemoglobinopathies Market.
Get Sample Copy of This Premium Report https://brandessenceresearch.com/requestSample/PostId/576
**The sample pages of this report is immediately accessible on-demand.**
A hemoglobinopathy is an inherited blood disorder in which person has an abnormal form of hemoglobin or decreased production of hemoglobin. Globally, hemoglobinopathies is one of the most common inherited diseases and much more common in northern and central Europe including Germany due to immigration. Clear understanding of the genetics and structure of the globin chains and Hb is required during the diagnosis of hemoglobinopathies. The most common hemoglobinopathies include the sickle cell disease (SCD) and thalassemias (alpha- and beta-). Hemoglobinopathies includes a large heterogeneous group of inherited disorders of hemoglobin synthesis that can be sub classified into thalassemia syndromes and structural hemoglobin variants.
Hemoglobinopathies Market report is segmented on the basis of application, diagnosis, end-user and regional & country level. Based upon application, hemoglobinopathies market is segmented into thalassemia, sickle cell disease (SCD) and others. Based upon diagnosis, hemoglobinopathies market is segmented as hemoglobin isoelectric focusing, hemoglobin electrophoresis, high performance liquid chromatography, genetic testing and hemoglobin solubility test. On the basis of end-user, the market is divided into hospitals, diagnosis laboratories and research laboratories.
The regions covered in this Global Hemoglobinopathies Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of Global hemoglobinopathies market is sub divided into U.S., Mexico, Canada, UK, France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
Some major key players for Hemoglobinopathies market are,
- Abbott Diagnostic
- Bio-Rad Laboratories Inc.
- Danaher Corporation
- Mindray Medical International Ltd
- Nexcelom Bioscience LLC.
- Nihon Kohden Corporation
- PerkinElmer Inc.
- Siemens Healthineers
- Sysmex Corporation
Increasing Cases of Sickle Cell Disorders and Thalassemia Coupled with Increasing Awareness of Healthcare is Expected to Grow the Global Hemoglobinopathies Market.
The hemoglobinopathies market is expected to witness a huge demand immensely from the past few years, mainly due to the increasing cases of the sickle cell diseases (SCD), β–thalassemia, and rising prevalence of blood related disorders among the individuals worldwide. WHO revealed that, around 7 % of the world’s population carries a hemoglobinopathy gene. In addition to this, screening and accurate identification of hemoglobin (Hb) variants have become extremely important in early days to carry out antenatal diagnosis and prevention of Hb disorders by the hemoglobinopathies. According to world health organization (WHO) reported that, nearly 5% of the world population is found with genetic hemoglobin (Hb) disorders and every year more than 42 million carriers and over 12,000 infants’ major and clinically significant hemoglobinopathy. Furthermore, new therapeutic approaches supported by favorable government initiatives from the emerging countries are fostering the growth of global hemoglobinopathies market. However, this approach is specifically required the unidirectional flow, proper training and relatively high cost can turn out to be restraining factor of this market.
North America is Expected to Dominating the Global Hemoglobinopathies Market.
North America is anticipated to dominate the hemoglobinopathies market during the forecast period. Increased immigration of high risk population along with the improved treatment and widespread presence of healthcare infrastructure has contributed to the vast implementation of newborn screening programs in this region. Nearly 70,000 to 100,000 Americans have sickle cell disease. The evolvement of non-sickling disorders, such as β thalassemia and Hb H disease varies across the US is largely required the testing solutions like Hemoglobinopathies. In addition, Asia pacific is exponentially growing region due to the fact that recent advancements in therapeutic approaches attaining the huge interest coupled with the rise in awareness of sickle cell diseases in this region.
Key Benefits for Market Report–
Global market report covers in depth historical and forecast analysis.
Global market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
Global market report helps to identify opportunities in market place.
Global market report covers extensive analysis of emerging trends and competitive landscape.
By Application: Thalassemia, Sickle cell disease (SCD), Others
By Diagnosis: Hemoglobin isoelectric focusing, Hemoglobin electrophoresis, High performance liquid chromatography, Genetic testing, Hemoglobin solubility test
By End-User: Hospitals, Diagnosis laboratories, Research laboratories
Regional & Country Analysis
North America, U.S., Mexico, Canada , Europe, UK, France, Germany, Italy , Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of Middle East and Africa
Request for Methodology Report @https://brandessenceresearch.com/requestMethodology/PostId/576
Table of Content
Chapter 1 Global Hemoglobinopathies Market: Summary and Quantitative Analysis
1.1 Report Description
1.2 Global Hemoglobinopathies Market Revenue Overview
1.3 Global Hemoglobinopathies Market Revenue (USD Billion) and Growth (%) Rate, 2015- 2025
Chapter 2 Global Hemoglobinopathies Market: Overview and Qualitative Analysis
2.1 Executive Summary
2.2 Market Drivers
2.2.1 Increasing need to improve the process in order to comply with new standards is anticipated to witness a high growth of Hemoglobinopathies Market
2.3 Market Restraints
2.4 Market Opportunities
2.5 Market Trends
2.6 Global Hemoglobinopathies Market: SWOT Analysis
2.7 Global Hemoglobinopathies Market: PEST Analysis
2.8 Global Hemoglobinopathies Market: Attractiveness Analysis
2.8.1 Global Hemoglobinopathies Market: Attractiveness Analysis by Type
2.8.2 Global Hemoglobinopathies Market: Attractiveness Analysis by Grade
2.8.3 Global Hemoglobinopathies Market: Attractiveness Analysis by Regional
Chapter 3 Competitive Analysis
3.1 Global Hemoglobinopathies Market
3.1.1 Global Hemoglobinopathies market Revenue (USD Billion), By Players 2018
3.1.2 Global Hemoglobinopathies Market Revenue Share (%), By Players 2018
Chapter 5 Global Hemoglobinopathies Market: By Types
5.1 Global Hemoglobinopathies Market Share (%), By Types, 2018
5.2 Global Hemoglobinopathies Market Revenue (USD Billion), By Types, 2015 – 2025
5.3 Global Hemoglobinopathies Market Revenue (USD Billion), Based,2015-2025
5.4 Global Hemoglobinopathies Market Revenue (USD Billion), Based,2015-2025
5.5 Global Hemoglobinopathies Market Revenue Share (%), By Types, 2015 – 2025
5.6 Global Hemoglobinopathies Market Revenue Market Share (%), By Types, 2015-2025
Chapter 6 Global Hemoglobinopathies Market: By Application
6.1 Global Hemoglobinopathies Market Share (%), By Application, 2018
6.2 Global Hemoglobinopathies Market Revenue (USD Billion), By Application, 2015 – 2025
6.3 Global Hemoglobinopathies Market Revenue (USD Billion), Enterprises, 2015-2025
6.4 Global Hemoglobinopathies Market Revenue (USD Billion),2015-2025
6.5 Global Hemoglobinopathies Market Revenue Share (%), By Application, 2015 – 2025
6.6 Global Hemoglobinopathies Market Revenue Market Share (%), By Application, 2015-2025
Chapter 7 North America Hemoglobinopathies Market Analysis
7.1 North America Market Snapshot
7.1.1 North America Hemoglobinopathies Market Revenue and Growth Rate (%), 2015-2025.
7.1.2 North America Hemoglobinopathies Market Revenue (USD Billion) Overview, by Country, 2015 – 2025
7.1.3 North America Hemoglobinopathies Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025.
7.1.4 North America Hemoglobinopathies Revenue (USD Billion) Overview, by Type, 2015-2025
7.1.5 North America Hemoglobinopathies Revenue (USD Billion) Overview, by Types, 2015-2025
7.1.6 North America Hemoglobinopathies Revenue (USD Billion) Overview, by Application , 2015-2025
About Us: Brandessence Market Research and Consulting Pvt. ltd.
Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.
Contact us at: +44-2038074155 or mail us at firstname.lastname@example.org
Article: https://businessstatsnews.com Blog: http://www.dailyindustrywatch.com Blog: https://marketsize.biz Blog: https://technologyindustrynews.com Blog: https://marketstatsreport.com Website: https://brandessenceresearch.com/ Blog:https://tcbiznews.com/